Array Discovery Capabilities

The challenges facing the pharmaceutical industry make the choice of a strategic discovery partner more important than ever. At Array BioPharma we offer a fully integrated, world-class small molecule drug discovery platform. Our experience allows us to harness this capability to move rapidly from hit identification through IND and clinical proof of concept.  During a research project, we seamlessly integrate proprietary compound collections, state of the art structural biology and computational chemistry with highly experienced medicinal chemists and biologists leading from the bench.

During the last ten years we have delivered 20 compounds into clinical development across multiple therapeutic areas including cancer, inflammation/pain, diabetes and infectious disease.

Learn more about our capabilities and approach below. 

hit-identification.png lead-optimization.pngind-enablement.png